A carregar...
Tyrosine Kinase Inhibitors Available for Chronic Myeloid Leukemia: Efficacy and Safety
Chronic myeloid leukemia (CML) is currently a disease in which patients can enjoy a near normal life-expectancy. However, since the majority of patients will need to remain on treatment indefinitely, physicians in care of CML patients need be familiar with the indications and toxicities of all appro...
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6617580/ https://ncbi.nlm.nih.gov/pubmed/31334123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00603 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|